General discussion, page-7337

Hey @Mujtabazafar

I think your question is best answered by aligning your Market Cap projections with some positive news that may come from some of the trials.
For instance some positive news from our IHL-42X Trials are due by end of Q4. (dec say)

That positive news should propel the SP to $1.00 in of itself Mkt Cap circa $1BLN (if we are not already at that level by then)
There is no other medicated therapy for sleep apnoea, this will be huge news and could actually take us a lot higher seeing that will have a bunch of more knowledgeable investors whom would appreciate the value investment here.

Then for the remainder of your Market Cap projections go to the next Trial and guestimate the "Probability of Success" which is the true driver of valuation. Let us know what you come up with we will all be very interested to know your thoughts.

Good luck @Mujtabazafar